Navigation Links
Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
Date:10/25/2010

n the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's lead investigational drug, torezolid phosphate, is an IV and orally administered second generation oxazolidinone in Phase 3 clinical development for the treatment of acute bacterial skin and skin structure infections (ABSSSI), the first such trial to be initiated under a Special Protocol Assessment (SPA). In addition to the company's torezolid phosphate clinical program, it is currently conducting two preclinical programs using its proprietary discovery platform to develop antibiotics to treat infections caused by gram-negative bacteria. For more information, visit www.triusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the potential benefits and protections afforded to Trius through current or potential patents and the potential duration of those benefits. Risks that contribute to the uncertain nature of the forward-looking statements include: Trius' ability to obtain additional financing; the success and timing of Trius' preclinical studies and clinical trials; regulatory developments in the United States and foreign countries; the performance of third-party manufacturers; changes in Trius' plans to develop and commercialize its product candidates; Trius' ability to obtain and maintain intellectual property protection for its product candidates; Trius' ability to freely commercialize its product candidates; and the loss of key scientific or management perso
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
2. Trius to Present at the Stifel Nicolaus Healthcare Conference
3. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
4. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
5. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
6. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
7. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
8. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
9. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
10. Trius Doses First Patient in Antibacterial Phase 2 Trial
11. PacificGMP Completes GMP Product Fill for Trius Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... CHENGDU, China , Jan. 23, 2015 Tianyin ... pharmaceutical company that specializes in the development and sale ... branded generics and active pharmaceutical ingredients (API) today announced ... Facility (JCM) API operation. 1. Following the ...
(Date:1/22/2015)... ON , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. ... with a focus on Omega-3 therapies for cardiovascular disease and ... of the Company,s accomplishments in 2014 and its outlook for ... Dear Fellow Shareholders, We would like to ...
(Date:1/22/2015)... Markets ( http://www.researchandmarkets.com/research/3h534b/infectious ) has announced the ... Product, Application, Technology, End User - Global Forecast to ... The infectious disease diagnostics market is expected to grow ... 2019 from $12,422.8 million in 2014. Increase in governmental ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3
... SALT LAKE CITY, Feb. 24, 2011 TechniScan ... company engaged in the development and commercialization of an automated ... signed agreements for manufacturing and use of trademarks with Austin, ... development agreement signed between the two companies in January 2011 ...
... 24, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ... year-end 2010 financial results on Thursday, March 3, 2011, after ... a conference call and webcast on Thursday, March 3, 2011 ... quarter and year-end 2010 financial results and highlights.  A live ...
Cached Medicine Technology:Breast Imaging Company, TechniScan, Signs Manufacturing Agreement With Texas Company 2Anadys Pharmaceuticals to Report Fourth Quarter and Year-end 2010 Financial Results 2
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved ... upcoming 32nd Annual Miami Breast Cancer Conference ... LLC (PER®) , shares that “a fast-growing, virulent” cancer ... she had not followed up her clean mammogram with ...
(Date:1/22/2015)... 22, 2015 IsoComforter, Inc. has introduced the ... patented IsoTube design to treat specific body parts and muscle ... progressive and easy to use patented cold therapy machine with ... related orthopedic and muscle injuries. IsoComforter has become the ...
(Date:1/22/2015)... 22, 2015 As interest in the value ... gains momentum worldwide, Rev. Eric J. Hall , president ... (HCCN), will be the keynote speaker on January 27 ... public health system. , The conference, “Hope and Resilience: Innovative ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... 23, 2010 Patients seeking to conserve privacy and ... to wear a traditional hospital gown that often reveal ... garb. Indeed, researchers from the University of Montreal have ... Alumna Nomie Marquis and Denyse Roy, a professor at ...
... children with autism see their careers disproportionally affected as they ... medical costs, according to a new study by researchers at ... a survey of 326 families in Washington and Oregon, found ... to accommodate the needs of their child and three out ...
... This release is available in Spanish . ... day as the brachytherapy implant in prostate cancer treatment manages ... This is the result of research undertaken at the University ... Brachytherapy , journal of the American Society of Brachytherapy. ...
... around, elderly people may want to think twice about taking ... the home, or wearing slippers or socks with no shoes, ... new study from the Institute for Aging Research of Hebrew ... the participants who reported a fall were either barefoot, wearing ...
... ... first time at how migraine sufferers experience the stigmatizing effects of their ... sufferers and more than those with other neurological diseases including stroke, epilepsy ... The research[i], presented at the American Headache ...
... LOS ANGELES (June 23, 2010) Some 19 percent ... is suspected in another 17 percent. While prevalence ... , little is known about sleep quality in soldiers ... A research team from the Madigan Army Medical Center ...
Cached Medicine News:Health News:No more peek-a-boo hospital gowns, no more bottoms up 2Health News:WSU researchers find mothers of children with autism pay price in workplace 2Health News:Optimizing brachytherapy dose on the same day as the implant can control prostate cancer 2Health News:Institute for Aging Research study says going barefoot in home may contribute to elderly falls 2Health News:Institute for Aging Research study says going barefoot in home may contribute to elderly falls 3Health News:Stigma of migraine is significant; worse for those with chronic migraine 2
... delivery and monitoring of inhaled Nitric Oxide., ... fully integrated, innovative instrument used to help ... INOvent delivery system works in combination with ... deliver a constant concentration of nitric oxide, ...
... Optilene Mesh Elastic is a lightweight and ... elasticity the mesh is able to adapt to ... The new honeycomb like structure with the large ... elastic scar. The mesh is ideal for incisional ...
... and user-friendly set-up of the Mega Power Electrosurgical ... ground running. The confusion and frustration associated ... past. Surgical teams have been asking for ... and easy to set-up. The Mega Power ...
... coronary artery surgery is the latest revolution ... being embraced world-wide by increasing numbers of ... but reduced mortality, stroke, and bleeding as ... A cardiac stabilizer is mandatory for this ...
Medicine Products: